{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:06:24Z","timestamp":1778767584993,"version":"3.51.4"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Czech Penumological and Phtiseological Society"},{"name":"The Ministry of Health of Czech Republic","award":["FNBr, 65269705"],"award-info":[{"award-number":["FNBr, 65269705"]}]},{"DOI":"10.13039\/501100001824","name":"The Czech Science Foundation","doi-asserted-by":"crossref","award":["GA23-06675S"],"award-info":[{"award-number":["GA23-06675S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Faculty of Medicine, Masaryk University, Czechia","award":["MUNI\/A\/1598\/2023"],"award-info":[{"award-number":["MUNI\/A\/1598\/2023"]}]},{"name":"Grant of Czech Agency for Medical Research","award":["NW24-06-00050"],"award-info":[{"award-number":["NW24-06-00050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03504-4","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:39:21Z","timestamp":1765431561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Insight into the pathogenesis of interstitial lung diseases and near-to-native lung fibrosis models"],"prefix":"10.1186","volume":"30","author":[{"given":"Marianna","family":"\u0160tef\u00e1nikov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Sedl\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00fcrkan","family":"Portakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ale\u0161","family":"Hampl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Va\u0148hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Doubkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"3504_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nm0511-552","volume":"17","author":"WZ Mehal","year":"2011","unstructured":"Mehal WZ, Iredale J, Friedman SL. Scraping fibrosis: expressway to the core of fibrosis. Nat Med. 2011;17:552\u20133.","journal-title":"Nat Med"},{"key":"3504_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/573210","volume":"2015","author":"S Yanagi","year":"2015","unstructured":"Yanagi S, Tsubouchi H, Miura A, Matsumoto N, Nakazato M. Breakdown of epithelial barrier integrity and overdrive activation of alveolar epithelial cells in the pathogenesis of acute respiratory distress syndrome and lung fibrosis. BioMed Res Int. 2015;2015:573210. https:\/\/doi.org\/10.1155\/2015\/573210.","journal-title":"BioMed Res Int"},{"key":"3504_CR3","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00018-020-03693-7","volume":"78","author":"THG Phan","year":"2021","unstructured":"Phan THG, Paliogiannis P, Nasrallah GK, Giordo R, Eid AH, Fois AG, et al. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cell Mol Life Sci. 2021;78:2031\u201357.","journal-title":"Cell Mol Life Sci"},{"key":"3504_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1164\/rccm.202004-1274OC","volume":"203","author":"C Yao","year":"2021","unstructured":"Yao C, Guan X, Carraro G, Parimon T, Liu X, Huang G, et al. Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis. Am J Respir Crit Care Med. 2021;203:707\u201317.","journal-title":"Am J Respir Crit Care Med"},{"key":"3504_CR5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205:e18-e47.","journal-title":"Am J Respir Crit Care Med"},{"key":"3504_CR6","doi-asserted-by":"publisher","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","volume":"3","author":"FJ Martinez","year":"2017","unstructured":"Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017;3:17074.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"3504_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.amjms.2019.02.009","volume":"357","author":"A Barros","year":"2019","unstructured":"Barros A, Oldham J, Noth I. Genetics of idiopathic pulmonary fibrosis. Am J Med Sci. 2019;357(5):379\u201383. https:\/\/doi.org\/10.1016\/j.amjms.2019.02.009.","journal-title":"Am J Med Sci"},{"key":"3504_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41439-019-0044-z","volume":"6","author":"M Doubkov\u00e1","year":"2019","unstructured":"Doubkov\u00e1 M, Sta\u0148o Kozub\u00edk K, Radov\u00e1 L, Pe\u0161ov\u00e1 M, Trizuljak J, P\u00e1l K, et al. A novel germline mutation of the SFTPA1 gene in familial interstitial pneumonia. Hum Genome Var. 2019;6:12.","journal-title":"Hum Genome Var"},{"key":"3504_CR9","doi-asserted-by":"publisher","first-page":"175346662110425","DOI":"10.1177\/17534666211042529","volume":"15","author":"M Doubkova","year":"2021","unstructured":"Doubkova M, Kriegova E, Littnerova S, Schneiderova P, Sterclova M, Bartos V, et al. DSP rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study. Ther Adv Respir Dis. 2021;15:17534666211042528.","journal-title":"Ther Adv Respir Dis"},{"key":"3504_CR10","volume":"56","author":"E Cocconcelli","year":"2020","unstructured":"Cocconcelli E, Biondini D, Bernardinello N, Baraldo S, Lococo S, Andreotti G, et al. Association between MUC5B rs35705950 genotype and response to antifibrotic treatment in patients with Idiopathic Pulmonary Fibrosis (IPF). Eur Respir J. 2020;56:735.","journal-title":"Eur Respir J"},{"issue":"6","key":"3504_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061993","volume":"9","author":"C Caliskan","year":"2020","unstructured":"Caliskan C, Seeliger B, J\u00e4ger B, Fuge J, Welte T, Terwolbeck O, et al. Genetic variation in CCL18 gene influences CCL18 expression and correlates with survival in Idiopathic Pulmonary Fibrosis\u2014Part B. J Clin Med. 2020;9(6):1993. https:\/\/doi.org\/10.3390\/jcm9061993.","journal-title":"J Clin Med"},{"issue":"3","key":"3504_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030372","volume":"11","author":"J \u0160elb","year":"2022","unstructured":"\u0160elb J, Osolnik K, Kern I, Koro\u0161ec P, Rijavec M. Utility of telomerase gene mutation testing in patients with Idiopathic Pulmonary Fibrosis in routine practice. Cells. 2022;11(3):372. https:\/\/doi.org\/10.3390\/cells11030372.","journal-title":"Cells"},{"key":"3504_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104766","volume":"95","author":"T Karampitsakos","year":"2023","unstructured":"Karampitsakos T, Juan-Guardela BM, Tzouvelekis A, Herazo-Maya JD. Precision medicine advances in idiopathic pulmonary fibrosis. EBioMedicine. 2023;95:104766. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104766.","journal-title":"EBioMedicine"},{"issue":"12","key":"3504_CR14","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1096\/fj.12-206458","volume":"26","author":"K Jensen","year":"2012","unstructured":"Jensen K, Nizamutdinov D, Guerrier M, Afroze S, Dostal D, Glaser S. General mechanisms of nicotine-induced fibrogenesis. FASEB J. 2012;26(12):4778\u201387. https:\/\/doi.org\/10.1096\/fj.12-206458.","journal-title":"FASEB J"},{"key":"3504_CR15","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/CIRCRESAHA.119.314936","volume":"124","author":"P Fughelli","year":"2019","unstructured":"Fughelli P, Stella A, Sterpetti AV. Marcello Malpighi (1628\u20131694). Circ Res. 2019;124:1430\u20132.","journal-title":"Circ Res"},{"issue":"7835","key":"3504_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41586-020-2922-4","volume":"587","author":"KJ Travaglini","year":"2020","unstructured":"Travaglini KJ, Nabhan AN, Penland L, Sinha R, Gillich A, Sit RV, et al. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature. 2020;587(7835):619\u201325. https:\/\/doi.org\/10.1038\/s41586-020-2922-4.","journal-title":"Nature"},{"issue":"5","key":"3504_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00408-022-00571-w","volume":"200","author":"W Zhu","year":"2022","unstructured":"Zhu W, Tan C, Zhang J. Alveolar epithelial type 2 cell dysfunction in idiopathic pulmonary fibrosis. Lung. 2022;200(5):539\u201347. https:\/\/doi.org\/10.1007\/s00408-022-00571-w.","journal-title":"Lung"},{"issue":"7","key":"3504_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05962-2","volume":"14","author":"MC Volpe","year":"2023","unstructured":"Volpe MC, Ciucci G, Zandomenego G, Vuerich R, Ring NAR, Vodret S, et al. Flt1 produced by lung endothelial cells impairs ATII cell transdifferentiation and repair in pulmonary fibrosis. Cell Death Dis. 2023;14(7):437. https:\/\/doi.org\/10.1038\/s41419-023-05962-2.","journal-title":"Cell Death Dis"},{"key":"3504_CR19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1164\/rccm.201312-2221PP","volume":"189","author":"M Selman","year":"2014","unstructured":"Selman M, Pardo A. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model. Am J Respir Crit Care Med. 2014;189:1161\u201372.","journal-title":"Am J Respir Crit Care Med"},{"key":"3504_CR20","first-page":"81","volume":"115","author":"RJ Mason","year":"1977","unstructured":"Mason RJ, Williams MC. Type II alveolar cell. Defender of the alveolus. Am Rev Respir Dis. 1977;115:81\u201391.","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"3504_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S2213-2600(19)30356-X","volume":"8","author":"SE Verleden","year":"2020","unstructured":"Verleden SE, Tanabe N, McDonough JE, Vasilescu DM, Xu F, Wuyts WA, et al. Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study. Lancet Respir Med. 2020;8(6):573\u201384. https:\/\/doi.org\/10.1016\/S2213-2600(19)30356-X.","journal-title":"Lancet Respir Med"},{"key":"3504_CR22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1164\/rccm.202103-0585OC","volume":"204","author":"K Ikezoe","year":"2021","unstructured":"Ikezoe K, Hackett TL, Peterson S, Prins D, Hague CJ, Murphy D, et al. Small airway reduction and fibrosis is an early pathologic feature of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2021;204:1048\u201359.","journal-title":"Am J Respir Crit Care Med"},{"key":"3504_CR23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1164\/rccm.202109-2219PP","volume":"206","author":"IT Stancil","year":"2022","unstructured":"Stancil IT, Michalski JE, Schwartz DA. An airway-centric view of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2022;206:410\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"3504_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1983","volume":"6","author":"TS Adams","year":"2020","unstructured":"Adams TS, Schupp JC, Poli S, Ayaub EA, Neumark N, Ahangari F, et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci Adv. 2020;6:eaba1983.","journal-title":"Sci Adv"},{"issue":"10","key":"3504_CR25","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/01.lab.0000032380.82232.67","volume":"82","author":"M Chilosi","year":"2002","unstructured":"Chilosi M, Poletti V, Murer B, Lestani M, Cancellieri A, Montagna L, et al. Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63. Lab Invest. 2002;82(10):1335\u201345. https:\/\/doi.org\/10.1097\/01.lab.0000032380.82232.67.","journal-title":"Lab Invest"},{"key":"3504_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.630096","volume":"12","author":"P Reynaud","year":"2021","unstructured":"Reynaud P, Ahmed E, Serre I, Knabe L, Bommart S, Suehs C, et al. Club cell loss as a feature of bronchiolization in ILD. Front Immunol. 2021;12:630096. https:\/\/doi.org\/10.3389\/fimmu.2021.630096.","journal-title":"Front Immunol"},{"issue":"2","key":"3504_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217230","volume":"80","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Distler O, Ryerson CJ, Tzouvelekis A, Lee JS, Bonella F, et al. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs). Ann Rheum Dis. 2021;80(2):143. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217230.","journal-title":"Ann Rheum Dis"},{"key":"3504_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar8356","volume":"10","author":"LJ Celada","year":"2018","unstructured":"Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT, et al. PD-1 up-regulation on CD4(+) T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production. Sci Transl Med. 2018;10:eaar8356.","journal-title":"Sci Transl Med"},{"key":"3504_CR29","doi-asserted-by":"publisher","first-page":"1802441","DOI":"10.1183\/13993003.02441-2018","volume":"54","author":"C Morse","year":"2019","unstructured":"Morse C, Tabib T, Sembrat J, Buschur KL, Bittar HT, Valenzi E, et al. Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur Respir J. 2019;54:1802441.","journal-title":"Eur Respir J"},{"key":"3504_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3892\/ijmm.2024.5413","volume":"54","author":"X Yang","year":"2024","unstructured":"Yang X, Liu Z, Zhou J, Guo J, Han T, Liu Y, et al. SPP1 promotes the polarization of M2 macrophages through the Jak2\/Stat3 signaling pathway and accelerates the progression of idiopathic pulmonary fibrosis. Int J Mol Med. 2024;54:89.","journal-title":"Int J Mol Med"},{"key":"3504_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12964-024-01557-2","volume":"22","author":"B-W Zhou","year":"2024","unstructured":"Zhou B-W, Liu H-M, Xu F, Jia X-H. The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review. Cell Commun Signal. 2024;22:172.","journal-title":"Cell Commun Signal"},{"key":"3504_CR32","doi-asserted-by":"publisher","first-page":"2004507","DOI":"10.1183\/13993003.04507-2020","volume":"58","author":"M Selman","year":"2021","unstructured":"Selman M, Pardo A. When things go wrong: exploring possible mechanisms driving the progressive fibrosis phenotype in interstitial lung diseases. Eur Respir J. 2021;58:2004507.","journal-title":"Eur Respir J"},{"issue":"1","key":"3504_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/01902149209020649","volume":"18","author":"SH Phan","year":"1992","unstructured":"Phan SH, Kunkel SL. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res. 1992;18(1):29\u201343. https:\/\/doi.org\/10.3109\/01902149209020649.","journal-title":"Exp Lung Res"},{"issue":"2","key":"3504_CR34","doi-asserted-by":"publisher","first-page":"954","DOI":"10.4049\/jimmunol.158.2.954","volume":"158","author":"K Zhang","year":"1997","unstructured":"Zhang K, Gharaee-Kermani M, McGarry B, Remick D, Phan SH. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J Immunol. 1997;158(2):954\u20139. https:\/\/doi.org\/10.4049\/jimmunol.158.2.954.","journal-title":"J Immunol"},{"key":"3504_CR35","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/jlb.64.4.528","volume":"64","author":"RE Smith","year":"1998","unstructured":"Smith RE, Strieter RM, Phan SH, Lukacs N, Kunkel SL. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury. J Leukoc Biol. 1998;64:528\u201336.","journal-title":"J Leukoc Biol"},{"key":"3504_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1165\/rcmb.2017-0034OC","volume":"59","author":"JM Lee","year":"2018","unstructured":"Lee JM, Yoshida M, Kim MS, Lee JH, Baek AR, Jang AS, et al. Involvement of alveolar epithelial cell necroptosis in idiopathic pulmonary fibrosis pathogenesis. Am J Respir Cell Mol Biol. 2018;59:215\u201324.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3504_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12931-023-02595-z","volume":"24","author":"X Ye","year":"2023","unstructured":"Ye X, Zhang M, Gu H, Liu M, Zhao Y, Shi Y, et al. Animal models of acute exacerbation of pulmonary fibrosis. Respir Res. 2023;24:296.","journal-title":"Respir Res"},{"key":"3504_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1165\/rcmb.2023-0426TR","volume":"71","author":"L Song","year":"2024","unstructured":"Song L, Li K, Chen H, Xie L. Cell cross-talk in alveolar microenvironment: from lung injury to fibrosis. Am J Respir Cell Mol Biol. 2024;71:30\u201342.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3504_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14503","volume":"24","author":"A Lingampally","year":"2025","unstructured":"Lingampally A, Truchi M, Shi X, Zhou Y, Vasquez-Pacheco E, Panagiotidis GD, et al. Unraveling alveolar fibroblast and activated myofibroblast heterogeneity and differentiation trajectories during lung fibrosis development and resolution in young and old mice. Aging Cell. 2025;24:e14503.","journal-title":"Aging Cell"},{"key":"3504_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1165\/rcmb.2022-0292OC","volume":"69","author":"X Liu","year":"2023","unstructured":"Liu X, Dai K, Zhang X, Huang G, Lynn H, Rabata A, et al. Multiple fibroblast subtypes contribute to matrix deposition in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2023;69:45\u201356.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3504_CR41","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41586-024-07660-1","volume":"631","author":"T Tsukui","year":"2024","unstructured":"Tsukui T, Wolters PJ, Sheppard D. Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis. Nature. 2024;631:627\u201334.","journal-title":"Nature"},{"key":"3504_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1972","volume":"6","author":"AC Habermann","year":"2020","unstructured":"Habermann AC, Gutierrez AJ, Bui LT, Yahn SL, Winters NI, Calvi CL, et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci Adv. 2020;6:eaba1972.","journal-title":"Sci Adv"},{"key":"3504_CR43","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI200420997","volume":"114","author":"RJ Phillips","year":"2004","unstructured":"Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004;114:438\u201346.","journal-title":"J Clin Invest"},{"key":"3504_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","volume":"16","author":"R Kramann","year":"2015","unstructured":"Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA, et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell. 2015;16:51\u201366.","journal-title":"Cell Stem Cell"},{"issue":"9807","key":"3504_CR45","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","volume":"378","author":"TE King Jr.","year":"2011","unstructured":"King TE Jr., Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378(9807):1949\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(11)60052-4.","journal-title":"Lancet"},{"issue":"1","key":"3504_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1172\/JCI93557","volume":"128","author":"J Herrera","year":"2018","unstructured":"Herrera J, Henke CA, Bitterman PB. Extracellular matrix as a driver of progressive fibrosis. J Clin Invest. 2018;128(1):45\u201353. https:\/\/doi.org\/10.1172\/JCI93557.","journal-title":"J Clin Invest"},{"issue":"17","key":"3504_CR47","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1091\/mbc.E19-12-0709","volume":"31","author":"VW Tang","year":"2020","unstructured":"Tang VW. Collagen, stiffness, and adhesion: the evolutionary basis of vertebrate mechanobiology. Mol Biol Cell. 2020;31(17):1823\u201334. https:\/\/doi.org\/10.1091\/mbc.E19-12-0709.","journal-title":"Mol Biol Cell"},{"issue":"148","key":"3504_CR48","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0033-2018","volume":"27","author":"C Upagupta","year":"2018","unstructured":"Upagupta C, Shimbori C, Alsilmi R, Kolb M. Matrix abnormalities in pulmonary fibrosis. Eur Respir Rev. 2018;27(148):180033. https:\/\/doi.org\/10.1183\/16000617.0033-2018.","journal-title":"Eur Respir Rev"},{"key":"3504_CR49","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1083\/jcb.200704042","volume":"179","author":"PJ Wipff","year":"2007","unstructured":"Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol. 2007;179:1311\u201323.","journal-title":"J Cell Biol"},{"key":"3504_CR50","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.ajpath.2014.02.003","volume":"184","author":"VJ Thannickal","year":"2014","unstructured":"Thannickal VJ, Henke CA, Horowitz JC, Noble PW, Roman J, Sime PJ, et al. Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute. Am J Pathol. 2014;184:1643\u201351.","journal-title":"Am J Pathol"},{"issue":"1","key":"3504_CR51","doi-asserted-by":"publisher","first-page":"L29","DOI":"10.1152\/ajplung.00173.2020","volume":"320","author":"XX Nguyen","year":"2021","unstructured":"Nguyen XX, Nishimoto T, Takihara T, Mlakar L, Bradshaw AD, Feghali-Bostwick C. Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis. Am J Physiol Lung Cell Mol Physiol. 2021;320(1):L29-l40. https:\/\/doi.org\/10.1152\/ajplung.00173.2020.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3504_CR52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.actbio.2024.02.008","volume":"177","author":"M Nizamoglu","year":"2024","unstructured":"Nizamoglu M, Alleblas F, Koster T, Borghuis T, Vonk JM, Thomas MJ, et al. Three dimensional fibrotic extracellular matrix directs microenvironment fiber remodeling by fibroblasts. Acta Biomater. 2024;177:118\u201331. https:\/\/doi.org\/10.1016\/j.actbio.2024.02.008.","journal-title":"Acta Biomater"},{"issue":"13","key":"3504_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23136894","volume":"23","author":"L Chuli\u00e1-Peris","year":"2022","unstructured":"Chuli\u00e1-Peris L, Carreres-Rey C, Gabasa M, Alcaraz J, Carretero J, Pereda J. Matrix metalloproteinases and their inhibitors in pulmonary fibrosis: EMMPRIN\/CD147 comes into play. Int J Mol Sci. 2022;23(13):6894. https:\/\/doi.org\/10.3390\/ijms23136894.","journal-title":"Int J Mol Sci"},{"key":"3504_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116255","volume":"228","author":"JK Burgess","year":"2024","unstructured":"Burgess JK, Gosens R. Mechanotransduction and the extracellular matrix: key drivers of lung pathologies and drug responsiveness. Biochem Pharmacol. 2024;228:116255. https:\/\/doi.org\/10.1016\/j.bcp.2024.116255.","journal-title":"Biochem Pharmacol"},{"key":"3504_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2024.106728","volume":"180","author":"M Ratnasingham","year":"2025","unstructured":"Ratnasingham M, Bradding P, Roach KM. The role of TRP channels in lung fibrosis: mechanisms and therapeutic potential. Int J Biochem Cell Biol. 2025;180:106728. https:\/\/doi.org\/10.1016\/j.biocel.2024.106728.","journal-title":"Int J Biochem Cell Biol"},{"key":"3504_CR56","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-981-10-7757-9_6","volume":"87","author":"A Samanta","year":"2018","unstructured":"Samanta A, Hughes TET, Moiseenkova-Bell VY. Transient receptor potential (TRP) channels. Subcell Biochem. 2018;87:141\u201365.","journal-title":"Subcell Biochem"},{"key":"3504_CR57","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/bph.14939","volume":"177","author":"KM Roach","year":"2020","unstructured":"Roach KM, Bradding P. Ca(2+) signalling in fibroblasts and the therapeutic potential of K(Ca)3.1 channel blockers in fibrotic diseases. Br J Pharmacol. 2020;177:1003\u201324.","journal-title":"Br J Pharmacol"},{"key":"3504_CR58","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1172\/JCI75331","volume":"124","author":"SO Rahaman","year":"2014","unstructured":"Rahaman SO, Grove LM, Paruchuri S, Southern BD, Abraham S, Niese KA, et al. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. J Clin Invest. 2014;124:5225\u201338.","journal-title":"J Clin Invest"},{"issue":"2","key":"3504_CR59","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbadis.2016.12.002","volume":"1863","author":"K Hofmann","year":"2017","unstructured":"Hofmann K, Fiedler S, Vierkotten S, Weber J, Klee S, Jia J, et al. Classical transient receptor potential 6 (TRPC6) channels support myofibroblast differentiation and development of experimental pulmonary fibrosis. Biochimica et Biophysica Acta (BBA). 2017;1863(2):560\u20138. https:\/\/doi.org\/10.1016\/j.bbadis.2016.12.002.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"3504_CR60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.matbio.2017.12.004","volume":"73","author":"AJ Haak","year":"2018","unstructured":"Haak AJ, Tan Q, Tschumperlin DJ. Matrix biomechanics and dynamics in pulmonary fibrosis. Matrix Biol. 2018;73:64\u201376. https:\/\/doi.org\/10.1016\/j.matbio.2017.12.004.","journal-title":"Matrix Biol"},{"key":"3504_CR61","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1172\/JCI71386","volume":"124","author":"MW Parker","year":"2014","unstructured":"Parker MW, Rossi D, Peterson M, Smith K, Sikstr\u00f6m K, White ES, et al. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest. 2014;124:1622\u201335.","journal-title":"J Clin Invest"},{"key":"3504_CR62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.actbio.2022.05.031","volume":"147","author":"M Nizamoglu","year":"2022","unstructured":"Nizamoglu M, de Hilster RHJ, Zhao F, Sharma PK, Borghuis T, Harmsen MC, et al. An in vitro model of fibrosis using crosslinked native extracellular matrix-derived hydrogels to modulate biomechanics without changing composition. Acta Biomater. 2022;147:50\u201362. https:\/\/doi.org\/10.1016\/j.actbio.2022.05.031.","journal-title":"Acta Biomater"},{"issue":"1","key":"3504_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-015-0237-z","volume":"16","author":"V Vicens-Zygmunt","year":"2015","unstructured":"Vicens-Zygmunt V, Estany S, Colom A, Montes-Worboys A, Machahua C, Sanabria AJ, et al. Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices. Respir Res. 2015;16(1):82. https:\/\/doi.org\/10.1186\/s12931-015-0237-z.","journal-title":"Respir Res"},{"issue":"1","key":"3504_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/path.4114","volume":"229","author":"AC Brown","year":"2013","unstructured":"Brown AC, Fiore VF, Sulchek TA, Barker TH. Physical and chemical microenvironmental cues orthogonally control the degree and duration of fibrosis-associated epithelial-to-mesenchymal transitions. J Pathol. 2013;229(1):25\u201335. https:\/\/doi.org\/10.1002\/path.4114.","journal-title":"J Pathol"},{"key":"3504_CR65","first-page":"213","volume":"119","author":"KK Kim","year":"2009","unstructured":"Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML, et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest. 2009;119:213\u201324.","journal-title":"J Clin Invest"},{"issue":"1","key":"3504_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-025-03201-0","volume":"26","author":"J Ba","year":"2025","unstructured":"Ba J, Zheng C, Lai Y, He X, Pan Y, Zhao Y, et al. High matrix stiffness promotes senescence of type II alveolar epithelial cells by lysosomal degradation of lamin A\/C in pulmonary fibrosis. Respir Res. 2025;26(1):128. https:\/\/doi.org\/10.1186\/s12931-025-03201-0.","journal-title":"Respir Res"},{"key":"3504_CR67","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1164\/rccm.201508-1638OC","volume":"194","author":"AR Froese","year":"2016","unstructured":"Froese AR, Shimbori C, Bellaye PS, Inman M, Obex S, Fatima S, et al. Stretch-induced activation of transforming growth factor-\u03b21 in pulmonary fibrosis. Am J Respir Crit Care Med. 2016;194:84\u201396.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3504_CR68","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6579\/aaca86","volume":"39","author":"TJ Wellman","year":"2018","unstructured":"Wellman TJ, Mondo\u00f1edo JR, Davis GS, Bates JHT, Suki B. Topographic distribution of idiopathic pulmonary fibrosis: a hybrid physics- and agent-based model. Physiol Meas. 2018;39(6):064007. https:\/\/doi.org\/10.1088\/1361-6579\/aaca86.","journal-title":"Physiol Meas"},{"key":"3504_CR69","doi-asserted-by":"crossref","unstructured":"Hall JK, Bates JHT, Casey DT, Bartol\u00e1k-Suki E, Lutchen KR, Suki B. Front Netw Physiol. 2023;3:1124223.","DOI":"10.3389\/fnetp.2023.1124223"},{"key":"3504_CR70","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/sym14010090","volume":"14","author":"N Cogno","year":"2022","unstructured":"Cogno N, Bauer R, Durante M. A 3D agent-based model of lung fibrosis. Symmetry. 2022;14:90.","journal-title":"Symmetry"},{"key":"3504_CR71","doi-asserted-by":"publisher","first-page":"1396383","DOI":"10.3389\/fnetp.2024.1396383","volume":"4","author":"JK Hall","year":"2024","unstructured":"Hall JK, Bates JHT, Krishnan R, Kim JH, Deng Y, Lutchen KR, et al. Elucidating the interaction between stretch and stiffness using an agent-based spring network model of progressive pulmonary fibrosis. Front Netw Physiol. 2024;4:1396383.","journal-title":"Front Netw Physiol."},{"issue":"6","key":"3504_CR72","doi-asserted-by":"publisher","first-page":"L991","DOI":"10.1152\/ajplung.00289.2018","volume":"315","author":"CL Wilson","year":"2018","unstructured":"Wilson CL, Stephenson SE, Higuero JP, Feghali-Bostwick C, Hung CF, Schnapp LM. Characterization of human PDGFR-\u03b2-positive pericytes from IPF and non-IPF lungs. Am J Physiol Lung Cell Mol Physiol. 2018;315(6):L991\u20131002. https:\/\/doi.org\/10.1152\/ajplung.00289.2018.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3504_CR73","doi-asserted-by":"publisher","first-page":"1150028","DOI":"10.3389\/fphys.2023.1150028","volume":"14","author":"AT Garrison","year":"2023","unstructured":"Garrison AT, Bignold RE, Wu X, Johnson JR. Pericytes: the lung-forgotten cell type. Front Physiol. 2023;14:1150028.","journal-title":"Front Physiol"},{"issue":"24","key":"3504_CR74","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96352","volume":"2","author":"P Sava","year":"2017","unstructured":"Sava P, Ramanathan A, Dobronyi A, Peng X, Sun H, Ledesma-Mendoza A, et al. Human pericytes adopt myofibroblast properties in the microenvironment of the IPF lung. JCI Insight. 2017;2(24):e96352. https:\/\/doi.org\/10.1172\/jci.insight.96352.","journal-title":"JCI Insight"},{"issue":"2","key":"3504_CR75","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbrc.2020.05.091","volume":"528","author":"M Yamaguchi","year":"2020","unstructured":"Yamaguchi M, Hirai S, Tanaka Y, Sumi T, Tada M, Takahashi H, et al. Pericyte-myofibroblast transition in the human lung. Biochem Biophys Res Commun. 2020;528(2):269\u201375. https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.091.","journal-title":"Biochem Biophys Res Commun"},{"key":"3504_CR76","doi-asserted-by":"crossref","unstructured":"Bradley J, O'Shea P, Wrench C, Mattsson J, Paulin R, Overed-Sayer C, Rosenberg L, Olsson H, Gianni D. A secretome screen in primary human lung fibroblasts identifies FGF9 as a novel regulator of cellular senescence. SLAS Discov. 2025;32:100223.","DOI":"10.1016\/j.slasd.2025.100223"},{"issue":"11","key":"3504_CR77","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41388-024-03236-5","volume":"44","author":"Y Lei","year":"2025","unstructured":"Lei Y, Zhong C, Zhang J, Zheng Q, Xu Y, Li Z, et al. Senescent lung fibroblasts in idiopathic pulmonary fibrosis facilitate non-small cell lung cancer progression by secreting exosomal MMP1. Oncogene. 2025;44(11):769\u201381. https:\/\/doi.org\/10.1038\/s41388-024-03236-5.","journal-title":"Oncogene"},{"issue":"1","key":"3504_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40617-y","volume":"14","author":"Y Enomoto","year":"2023","unstructured":"Enomoto Y, Katsura H, Fujimura T, Ogata A, Baba S, Yamaoka A, et al. Autocrine TGF-\u03b2-positive feedback in profibrotic AT2-lineage cells plays a crucial role in non-inflammatory lung fibrogenesis. Nat Commun. 2023;14(1):4956. https:\/\/doi.org\/10.1038\/s41467-023-40617-y.","journal-title":"Nat Commun"},{"key":"3504_CR79","doi-asserted-by":"crossref","unstructured":"Xie T, Liang J, Stripp B, Noble PW. Cell-cell interactions and communication dynamics in lung fibrosis. Chin Med J Pulm Crit Care Med. 2024;2:63\u201371.","DOI":"10.1016\/j.pccm.2024.04.001"},{"key":"3504_CR80","doi-asserted-by":"publisher","first-page":"1557848","DOI":"10.3389\/fimmu.2025.1557848","volume":"16","author":"S Weng","year":"2025","unstructured":"Weng S, Zuo J, Mo J, Ye L. Cellular senescence-related gene signatures in idiopathic pulmonary fibrosis: insights from bioinformatics. Front Immunol. 2025;16:1557848.","journal-title":"Front Immunol"},{"key":"3504_CR81","doi-asserted-by":"publisher","first-page":"L1164","DOI":"10.1152\/ajplung.00220.2017","volume":"313","author":"D \u00c1lvarez","year":"2017","unstructured":"\u00c1lvarez D, C\u00e1rdenes N, Sellar\u00e9s J, Bueno M, Corey C, Hanumanthu VS, et al. IPF lung fibroblasts have a senescent phenotype. Am J Physiol Lung Cell Mol Physiol. 2017;313:L1164-l1173.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3504_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12040389","volume":"24","author":"KEC Blokland","year":"2020","unstructured":"Blokland KEC, Waters DW, Schuliga M, Read J, Pouwels SD, Grainge CL, et al. Senescence of IPF lung fibroblasts disrupt alveolar epithelial cell proliferation and promote migration in wound healing. Pharmaceutics. 2020;24:389.","journal-title":"Pharmaceutics"},{"key":"3504_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.924754","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Guo Z, Ma R, Wang J, Wu N, Fan Y, et al. Prognostic predictive characteristics in patients with fibrosing interstitial lung disease: a retrospective cohort study. Front Pharmacol. 2022;13:924754. https:\/\/doi.org\/10.3389\/fphar.2022.924754.","journal-title":"Front Pharmacol"},{"key":"3504_CR84","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/his.14334","volume":"79","author":"JS Lee","year":"2021","unstructured":"Lee JS, La J, Aziz S, Dobrinskikh E, Brownell R, Jones KD, et al. Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis. Histopathology. 2021;79:67\u201376.","journal-title":"Histopathology"},{"key":"3504_CR85","doi-asserted-by":"publisher","first-page":"1900809","DOI":"10.1183\/13993003.00809-2019","volume":"54","author":"TW Hoffman","year":"2019","unstructured":"Hoffman TW, van der Vis JJ, van der Smagt JJ, Massink MPG, Grutters JC, van Moorsel CHM. Pulmonary fibrosis linked to variants in the ACD gene, encoding the telomere protein TPP1. Eur Respir J. 2019;54:1900809.","journal-title":"Eur Respir J"},{"key":"3504_CR86","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1369\/0022155415617988","volume":"64","author":"DR Newman","year":"2016","unstructured":"Newman DR, Sills WS, Hanrahan K, Ziegler A, Tidd KM, Cook E, et al. Expression of WNT5A in idiopathic pulmonary fibrosis and its control by TGF-\u03b2 and WNT7B in human lung fibroblasts. J Histochem Cytochem. 2016;64:99\u2013111.","journal-title":"J Histochem Cytochem"},{"key":"3504_CR87","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/genes9120588","volume":"9","author":"S Mullenbrock","year":"2018","unstructured":"Mullenbrock S, Liu F, Szak S, Hronowski X, Gao B, Juhasz P, et al. Systems analysis of transcriptomic and proteomic profiles identifies novel regulation of fibrotic programs by miRNAs in pulmonary fibrosis fibroblasts. Genes. 2018;9:588.","journal-title":"Genes"},{"issue":"22","key":"3504_CR88","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131597","volume":"4","author":"JE McDonough","year":"2019","unstructured":"McDonough JE, Ahangari F, Li Q, Jain S, Verleden SE, Herazo-Maya J, et al. Transcriptional regulatory model of fibrosis progression in the human lung. JCI Insight. 2019;4(22):e131597. https:\/\/doi.org\/10.1172\/jci.insight.131597.","journal-title":"JCI Insight"},{"issue":"4","key":"3504_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100056","volume":"1","author":"J Zhang","year":"2020","unstructured":"Zhang J, Muise ES, Han S, Kutchukian PS, Costet P, Zhu Y, et al. Molecular profiling reveals a common metabolic signature of tissue fibrosis. Cell Rep Med. 2020;1(4):100056. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100056.","journal-title":"Cell Rep Med"},{"key":"3504_CR90","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00018-021-04094-0","volume":"79","author":"P Zheng","year":"2022","unstructured":"Zheng P, Sun S, Wang J, Cheng ZJ, Lei KC, Xue M, et al. Integrative omics analysis identifies biomarkers of idiopathic pulmonary fibrosis. Cell Mol Life Sci. 2022;79:66.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3504_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02435-0","volume":"24","author":"P Ruan","year":"2023","unstructured":"Ruan P, Todd JL, Zhao H, Liu Y, Vinisko R, Soellner JF, et al. Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression. Respir Res. 2023;24(1):141. https:\/\/doi.org\/10.1186\/s12931-023-02435-0.","journal-title":"Respir Res"},{"issue":"1","key":"3504_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01860-3","volume":"22","author":"P Sivakumar","year":"2021","unstructured":"Sivakumar P, Ammar R, Thompson JR, Luo Y, Streltsov D, Porteous M, et al. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis. Respir Res. 2021;22(1):273. https:\/\/doi.org\/10.1186\/s12931-021-01860-3.","journal-title":"Respir Res"},{"key":"3504_CR93","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1164\/rccm.200501-017PP","volume":"172","author":"VL Kinnula","year":"2005","unstructured":"Kinnula VL, Fattman CL, Tan RJ, Oury TD. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med. 2005;172:417\u201322.","journal-title":"Am J Respir Crit Care Med"},{"key":"3504_CR94","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1165\/rcmb.2019-0328TR","volume":"62","author":"SM Ruwanpura","year":"2020","unstructured":"Ruwanpura SM, Thomas BJ, Bardin PG. Pirfenidone: molecular mechanisms and potential clinical applications in lung disease. Am J Respir Cell Mol Biol. 2020;62:413\u201322.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3504_CR95","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pupt.2018.10.006","volume":"53","author":"Z Ma","year":"2018","unstructured":"Ma Z, Zhao C, Chen Q, Yu C, Zhang H, Zhang Z, et al. Antifibrotic effects of a novel pirfenidone derivative in vitro and in vivo. Pulm Pharmacol Ther. 2018;53:100\u20136. https:\/\/doi.org\/10.1016\/j.pupt.2018.10.006.","journal-title":"Pulm Pharmacol Ther"},{"key":"3504_CR96","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1165\/rcmb.2005-0452OC","volume":"35","author":"A Hirano","year":"2006","unstructured":"Hirano A, Kanehiro A, Ono K, Ito W, Yoshida A, Okada C, et al. Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge. Am J Res Cell Mol Biol. 2006;35:366\u201377.","journal-title":"Am J Res Cell Mol Biol"},{"key":"3504_CR97","first-page":"L311","volume":"276","author":"G Gurujeyalakshmi","year":"1999","unstructured":"Gurujeyalakshmi G, Hollinger MA, Giri SN. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level. Am J Physiol. 1999;276:L311-318.","journal-title":"Am J Physiol"},{"issue":"2","key":"3504_CR98","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1124\/jpet.113.208223","volume":"349","author":"L Wollin","year":"2014","unstructured":"Wollin L, Maillet I, Quesniaux V, Holweg A, Ryffel B. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. J Pharmacol Exp Ther. 2014;349(2):209\u201320. https:\/\/doi.org\/10.1124\/jpet.113.208223.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"3504_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-014-0157-3","volume":"15","author":"KE Hostettler","year":"2014","unstructured":"Hostettler KE, Zhong J, Papakonstantinou E, Karakiulakis G, Tamm M, Seidel P, et al. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis. Respir Res. 2014;15(1):157. https:\/\/doi.org\/10.1186\/s12931-014-0157-3.","journal-title":"Respir Res"},{"issue":"131","key":"3504_CR100","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1183\/09059180.00008913","volume":"23","author":"L Crin\u00f2","year":"2014","unstructured":"Crin\u00f2 L, Metro G. Therapeutic options targeting angiogenesis in nonsmall cell lung cancer. Eur Respir Rev. 2014;23(131):79\u201391. https:\/\/doi.org\/10.1183\/09059180.00008913.","journal-title":"Eur Respir Rev"},{"issue":"11","key":"3504_CR101","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1164\/rccm.2403006","volume":"169","author":"EA Renzoni","year":"2004","unstructured":"Renzoni EA. Neovascularization in idiopathic pulmonary fibrosis: too much or too little? Am J Respir Crit Care Med. 2004;169(11):1179\u201380. https:\/\/doi.org\/10.1164\/rccm.2403006.","journal-title":"Am J Respir Crit Care Med"},{"key":"3504_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.679388","volume":"12","author":"KM Roach","year":"2021","unstructured":"Roach KM, Castells E, Dixon K, Mason S, Elliott G, Marshall H, et al. Evaluation of pirfenidone and nintedanib in a human lung model of fibrogenesis. Front Pharmacol. 2021;12:679388. https:\/\/doi.org\/10.3389\/fphar.2021.679388.","journal-title":"Front Pharmacol"},{"key":"3504_CR103","doi-asserted-by":"crossref","unstructured":"Reininger D, Wolf F, Mayr CH, Wespel SL, Laufhaeger N, Geillinger-K\u00e4stle K, Dick A, Gantner F, Nickolaus P, Herrmann FE. Insights into the Cellular and Molecular Mechanisms Behind the Antifibrotic Effects of Nerandomilast. Am J Respir Cell Mol Biol. 2025. Online ahead of print.","DOI":"10.1165\/rcmb.2024-0614OC"},{"issue":"22","key":"3504_CR104","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1056\/NEJMoa2503643","volume":"392","author":"TM Maher","year":"2025","unstructured":"Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, et al. Nerandomilast in patients with progressive pulmonary fibrosis. N Engl J Med. 2025;392(22):2203\u201314. https:\/\/doi.org\/10.1056\/NEJMoa2503643.","journal-title":"N Engl J Med"},{"key":"3504_CR105","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","volume":"392","author":"L Richeldi","year":"2025","unstructured":"Richeldi L, Azuma A, Cottin V, Kreuter M, Maher TM, Martinez FJ, et al. Nerandomilast in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2025;392:2193\u2013202.","journal-title":"N Engl J Med"},{"issue":"5","key":"3504_CR106","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/art.39575","volume":"68","author":"H Sun","year":"2016","unstructured":"Sun H, Zhu Y, Pan H, Chen X, Balestrini JL, Lam TT, et al. Netrin-1 regulates fibrocyte accumulation in the decellularized fibrotic sclerodermatous lung microenvironment and in bleomycin-induced pulmonary fibrosis. Arthritis Rheumatol. 2016;68(5):1251\u201361. https:\/\/doi.org\/10.1002\/art.39575.","journal-title":"Arthritis Rheumatol"},{"key":"3504_CR107","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/gb-2009-10-9-239","volume":"10","author":"S Rajasekharan","year":"2009","unstructured":"Rajasekharan S, Kennedy TE. The netrin protein family. Genome Biol. 2009;10:239.","journal-title":"Genome Biol"},{"issue":"6","key":"3504_CR108","doi-asserted-by":"publisher","first-page":"L984","DOI":"10.1152\/ajplung.00053.2017","volume":"314","author":"JL van der Velden","year":"2018","unstructured":"van der Velden JL, Wagner DE, Lahue KG, Abdalla ST, Lam YW, Weiss DJ, et al. TGF-\u03b21-induced deposition of provisional extracellular matrix by tracheal basal cells promotes epithelial-to-mesenchymal transition in a c-Jun NH(2)-terminal kinase-1-dependent manner. Am J Physiol Lung Cell Mol Physiol. 2018;314(6):L984-l997. https:\/\/doi.org\/10.1152\/ajplung.00053.2017.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3504_CR109","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1164\/rccm.202310-1907OC","volume":"210","author":"W Mattos","year":"2024","unstructured":"Mattos W, Khalil N, Spencer LG, Bonella F, Folz RJ, Rolf JD, et al. Phase 2, double-blind, placebo-controlled trial of a c-Jun N-terminal kinase inhibitor in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2024;210:435\u201343.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3504_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18555-9","volume":"8","author":"KM Roach","year":"2018","unstructured":"Roach KM, Sutcliffe A, Matthews L, Elliott G, Newby C, Amrani Y, et al. A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis. Sci Rep. 2018;8(1):342. https:\/\/doi.org\/10.1038\/s41598-017-18555-9.","journal-title":"Sci Rep"},{"key":"3504_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56412-z","volume":"9","author":"HB Derseh","year":"2019","unstructured":"Derseh HB, Dewage SNV, Perera KUE, Pagel CN, Koumoundouros E, Organ L, et al. K(Ca)3.1 channel blockade attenuates microvascular remodelling in a large animal model of bleomycin-induced pulmonary fibrosis. Sci Rep. 2019;9:19893.","journal-title":"Sci Rep"},{"key":"3504_CR112","unstructured":"Senicapoc in Patients with Worsening Fibrotic Interstitial Lung Disease [https:\/\/trial.medpath.com\/clinical-trial\/4b33d331b2774e26\/nct06714123-senicapoc-fibrotic-ild-ipf-prevention]"},{"key":"3504_CR113","first-page":"43","volume":"16","author":"A Vats","year":"2023","unstructured":"Vats A, Chaturvedi P. The regenerative power of stem cells. Treating bleomycin-induced lung fibrosis. Stem Cells Cloning. 2023;16:43\u201359.","journal-title":"Stem Cells Cloning"},{"key":"3504_CR114","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7486279","volume":"2019","author":"V Miceli","year":"2019","unstructured":"Miceli V, Pampalone M, Vella S, Carreca AP, Amico G, Conaldi PG. Comparison of immunosuppressive and angiogenic properties of human amnion-derived mesenchymal stem cells between 2D and 3D culture systems. Stem Cells Int. 2019;2019:7486279. https:\/\/doi.org\/10.1155\/2019\/7486279.","journal-title":"Stem Cells Int"},{"key":"3504_CR115","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5083797","volume":"2018","author":"J Shu","year":"2018","unstructured":"Shu J, He X, Li H, Liu X, Qiu X, Zhou T, et al. The beneficial effect of human amnion mesenchymal cells in inhibition of inflammation and induction of neuronal repair in EAE mice. J Immunol Res. 2018;2018:5083797. https:\/\/doi.org\/10.1155\/2018\/5083797.","journal-title":"J Immunol Res"},{"issue":"1","key":"3504_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01863-0","volume":"22","author":"ML Decaris","year":"2021","unstructured":"Decaris ML, Schaub JR, Chen C, Cha J, Lee GG, Rexhepaj M, et al. Dual inhibition of \u03b1v\u03b26 and \u03b1v\u03b21 reduces fibrogenesis in lung tissue explants from patients with IPF. Respir Res. 2021;22(1):265. https:\/\/doi.org\/10.1186\/s12931-021-01863-0.","journal-title":"Respir Res"},{"issue":"3","key":"3504_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103396","volume":"392","author":"M Birker-Robaczewska","year":"2025","unstructured":"Birker-Robaczewska M, Boucher M, Ranieri G, Poirey S, Studer R, Freti D, et al. The novel lysophosphatidic acid receptor 1-selective antagonist, ACT-1016-0707, has unique binding properties that translate into effective antifibrotic and anti-inflammatory activity in different models of pulmonary fibrosis. J Pharmacol Exp Ther. 2025;392(3):103396. https:\/\/doi.org\/10.1016\/j.jpet.2025.103396.","journal-title":"J Pharmacol Exp Ther"},{"key":"3504_CR118","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32:40\u201351.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"3504_CR119","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.drudis.2019.03.006","volume":"24","author":"V Sedl\u00e1kov\u00e1","year":"2019","unstructured":"Sedl\u00e1kov\u00e1 V, Klou\u010dkov\u00e1 M, Garl\u00edkov\u00e1 Z, Va\u0161\u00ed\u010dkov\u00e1 K, Jaro\u0161 J, Kandra M, et al. Options for modeling the respiratory system: inserts, scaffolds and microfluidic chips. Drug Discov Today. 2019;24(4):971\u201382. https:\/\/doi.org\/10.1016\/j.drudis.2019.03.006.","journal-title":"Drug Discov Today"},{"issue":"8","key":"3504_CR120","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/17460441.2020.1755252","volume":"15","author":"T Yanagihara","year":"2020","unstructured":"Yanagihara T, Chong SG, Vierhout M, Hirota JA, Ask K, Kolb M. Current models of pulmonary fibrosis for future drug discovery efforts. Expert Opin Drug Discov. 2020;15(8):931\u201341. https:\/\/doi.org\/10.1080\/17460441.2020.1755252.","journal-title":"Expert Opin Drug Discov"},{"key":"3504_CR121","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.addr.2017.12.013","volume":"129","author":"A Sundarakrishnan","year":"2018","unstructured":"Sundarakrishnan A, Chen Y, Black LD, Aldridge BB, Kaplan DL. Engineered cell and tissue models of pulmonary fibrosis. Adv Drug Deliv Rev. 2018;129:78\u201394. https:\/\/doi.org\/10.1016\/j.addr.2017.12.013.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3504_CR122","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","volume":"40","author":"A Moeller","year":"2008","unstructured":"Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008;40(3):362\u201382. https:\/\/doi.org\/10.1016\/j.biocel.2007.08.011.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"3504_CR123","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1165\/rcmb.2005-0062TR","volume":"33","author":"F Chua","year":"2005","unstructured":"Chua F, Gauldie J, Laurent GJ. Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol. 2005;33(1):9\u201313. https:\/\/doi.org\/10.1165\/rcmb.2005-0062TR.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"3504_CR124","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1021\/acsbiomaterials.8b01262","volume":"5","author":"A Sundarakrishnan","year":"2019","unstructured":"Sundarakrishnan A, Zukas H, Coburn J, Bertini BT, Liu Z, Georgakoudi I, et al. Bioengineered in vitro tissue model of fibroblast activation for modeling pulmonary fibrosis. ACS Biomater Sci Eng. 2019;5(5):2417\u201329. https:\/\/doi.org\/10.1021\/acsbiomaterials.8b01262.","journal-title":"ACS Biomater Sci Eng"},{"key":"3504_CR125","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.semcdb.2019.11.006","volume":"100","author":"MC Basil","year":"2020","unstructured":"Basil MC, Morrisey EE. Lung regeneration: a tale of mice and men. Semin Cell Dev Biol. 2020;100:88\u2013100. https:\/\/doi.org\/10.1016\/j.semcdb.2019.11.006.","journal-title":"Semin Cell Dev Biol"},{"key":"3504_CR126","first-page":"63","volume":"127","author":"DJ Schrier","year":"1983","unstructured":"Schrier DJ, Kunkel RG, Phan SH. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am J Respir Crit Care Med. 1983;127:63\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"3504_CR127","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01209-2017","volume":"50","author":"G Raghu","year":"2017","unstructured":"Raghu G. Idiopathic pulmonary fibrosis. Lessons from clinical trials over the past 25\u2005years. Eur Respir J. 2017;50:1701209.","journal-title":"Eur Respir J"},{"issue":"1","key":"3504_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0480-7","volume":"13","author":"L Fregonese","year":"2015","unstructured":"Fregonese L, Eichler I. The future of the development of medicines in idiopathic pulmonary fibrosis. BMC Med. 2015;13(1):239. https:\/\/doi.org\/10.1186\/s12916-015-0480-7.","journal-title":"BMC Med"},{"key":"3504_CR129","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1165\/rcmb.2017-0096ST","volume":"56","author":"RG Jenkins","year":"2017","unstructured":"Jenkins RG, Moore BB, Chambers RC, Eickelberg O, K\u00f6nigshoff M, Kolb M, et al. An official American Thoracic Society workshop report. Use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis. Am J Respir Cell Mol Biol. 2017;56:667\u201379.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"3504_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043149","volume":"24","author":"Y Ishida","year":"2023","unstructured":"Ishida Y, Kuninaka Y, Mukaida N, Kondo T. Immune mechanisms of pulmonary fibrosis with bleomycin. Int J Mol Sci. 2023;24(4):3149. https:\/\/doi.org\/10.3390\/ijms24043149.","journal-title":"Int J Mol Sci"},{"key":"3504_CR131","first-page":"531","volume":"96","author":"IY Adamson","year":"1979","unstructured":"Adamson IY, Bowden DH. Bleomycin-induced injury and metaplasia of alveolar type 2 cells. Relationship of cellular responses to drug presence in the lung. Am J Pathol. 1979;96:531\u201344.","journal-title":"Am J Pathol"},{"issue":"6","key":"3504_CR132","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01105-2019","volume":"55","author":"P Kolb","year":"2020","unstructured":"Kolb P, Upagupta C, Vierhout M, Ayaub E, Bellaye PS, Gauldie J, et al. The importance of interventional timing in the bleomycin model of pulmonary fibrosis. Eur Respir J. 2020;55(6):1901105. https:\/\/doi.org\/10.1183\/13993003.01105-2019.","journal-title":"Eur Respir J"},{"issue":"1","key":"3504_CR133","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2307\/3577022","volume":"111","author":"RL Karvonen","year":"1987","unstructured":"Karvonen RL, Fernandez-Madrid F, Maughan RL, Palmer KC, Fernandez-Madrid I. An animal model of pulmonary radiation fibrosis with biochemical, physiologic, immunologic, and morphologic observations. Radiat Res. 1987;111(1):68\u201380. https:\/\/doi.org\/10.2307\/3577022.","journal-title":"Radiat Res"},{"issue":"4","key":"3504_CR134","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1172\/JCI119590","volume":"100","author":"PJ Sime","year":"1997","unstructured":"Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest. 1997;100(4):768\u201376. https:\/\/doi.org\/10.1172\/JCI119590.","journal-title":"J Clin Invest"},{"key":"3504_CR135","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0002-9440(10)65624-6","volume":"153","author":"PJ Sime","year":"1998","unstructured":"Sime PJ, Marr RA, Gauldie D, Xing Z, Hewlett BR, Graham FL, et al. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. Am J Pathol. 1998;153:825\u201332.","journal-title":"Am J Pathol"},{"key":"3504_CR136","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1172\/JCI12568","volume":"107","author":"M Kolb","year":"2001","unstructured":"Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest. 2001;107:1529\u201336.","journal-title":"J Clin Invest"},{"issue":"9","key":"3504_CR137","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1172\/JCI99287","volume":"128","author":"SI Nureki","year":"2018","unstructured":"Nureki SI, Tomer Y, Venosa A, Katzen J, Russo SJ, Jamil S, et al. Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis. J Clin Invest. 2018;128(9):4008\u201324. https:\/\/doi.org\/10.1172\/JCI99287.","journal-title":"J Clin Invest"},{"issue":"2","key":"3504_CR138","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.celrep.2015.06.028","volume":"12","author":"JM Povedano","year":"2015","unstructured":"Povedano JM, Martinez P, Flores JM, Mulero F, Blasco MA. Mice with pulmonary fibrosis driven by telomere dysfunction. Cell Rep. 2015;12(2):286\u201399. https:\/\/doi.org\/10.1016\/j.celrep.2015.06.028.","journal-title":"Cell Rep"},{"key":"3504_CR139","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1038\/s41467-018-07768-9","volume":"9","author":"LA Hancock","year":"2018","unstructured":"Hancock LA, Hennessy CE, Solomon GM, Dobrinskikh E, Estrella A, Hara N, et al. Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice. Nat Commun. 2018;9:5363.","journal-title":"Nat Commun"},{"key":"3504_CR140","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1165\/rcmb.2006-0469OC","volume":"37","author":"LR Young","year":"2007","unstructured":"Young LR, Pasula R, Gulleman PM, Deutsch GH, McCormack FX. Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis. Am J Respir Cell Mol Biol. 2007;37:67\u201374.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"3504_CR141","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.stemcr.2019.01.014","volume":"12","author":"Y Korogi","year":"2019","unstructured":"Korogi Y, Gotoh S, Ikeo S, Yamamoto Y, Sone N, Tamai K, et al. In vitro disease modeling of Hermansky-Pudlak syndrome type 2 using human induced pluripotent stem cell-derived alveolar organoids. Stem Cell Reports. 2019;12(3):431\u201340. https:\/\/doi.org\/10.1016\/j.stemcr.2019.01.014.","journal-title":"Stem Cell Reports"},{"issue":"4","key":"3504_CR142","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ajpath.2017.12.020","volume":"188","author":"DM Habiel","year":"2018","unstructured":"Habiel DM, Espindola MS, Coelho AL, Hogaboam CM. Modeling idiopathic pulmonary fibrosis in humanized severe combined immunodeficient mice. Am J Pathol. 2018;188(4):891\u2013903. https:\/\/doi.org\/10.1016\/j.ajpath.2017.12.020.","journal-title":"Am J Pathol"},{"issue":"6","key":"3504_CR143","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125326","volume":"4","author":"Y Geng","year":"2019","unstructured":"Geng Y, Liu X, Liang J, Habiel DM, Kulur V, Coelho AL, et al. PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis. JCI insight. 2019;4(6):e125326. https:\/\/doi.org\/10.1172\/jci.insight.125326.","journal-title":"JCI insight"},{"issue":"1","key":"3504_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther. 2023;8(1):160. https:\/\/doi.org\/10.1038\/s41392-023-01419-2.","journal-title":"Signal Transduct Target Ther"},{"key":"3504_CR145","volume-title":"The principles of humane experimental technique","author":"W Russell","year":"1959","unstructured":"Russell W, Burch R. The principles of humane experimental technique. London: Methuen & Co. Ltd.; 1959."},{"issue":"1","key":"3504_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-02855-6","volume":"25","author":"C Koziol-White","year":"2024","unstructured":"Koziol-White C, Gebski E, Cao G, Panettieri RA Jr. Precision cut lung slices: an integrated ex vivo model for studying lung physiology, pharmacology, disease pathogenesis and drug discovery. Respir Res. 2024;25(1):231. https:\/\/doi.org\/10.1186\/s12931-024-02855-6.","journal-title":"Respir Res"},{"issue":"6","key":"3504_CR147","doi-asserted-by":"publisher","first-page":"L896","DOI":"10.1152\/ajplung.00084.2017","volume":"312","author":"HN Alsafadi","year":"2017","unstructured":"Alsafadi HN, Staab-Weijnitz CA, Lehmann M, Lindner M, Peschel B, K\u00f6nigshoff M, et al. An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices. Am J Physiol Lung Cell Mol Physiol. 2017;312(6):L896-l902. https:\/\/doi.org\/10.1152\/ajplung.00084.2017.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"3504_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0876-y","volume":"19","author":"M Lehmann","year":"2018","unstructured":"Lehmann M, Buhl L, Alsafadi HN, Klee S, Hermann S, Mutze K, et al. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis. Respir Res. 2018;19(1):175. https:\/\/doi.org\/10.1186\/s12931-018-0876-y.","journal-title":"Respir Res"},{"issue":"4","key":"3504_CR149","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.resinv.2020.01.003","volume":"58","author":"H Ihara","year":"2020","unstructured":"Ihara H, Mitsuishi Y, Kato M, Takahashi F, Tajima K, Hayashi T, et al. Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-\u03b2\/Smad pathway. Respir Investig. 2020;58(4):275\u201384. https:\/\/doi.org\/10.1016\/j.resinv.2020.01.003.","journal-title":"Respir Investig"},{"key":"3504_CR150","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.vascn.2017.02.023","volume":"86","author":"K Togami","year":"2017","unstructured":"Togami K, Yamaguchi K, Chono S, Tada H. Evaluation of permeability alteration and epithelial\u2013mesenchymal transition induced by transforming growth factor-\u03b21 in A549, NCI-H441, and Calu-3 cells: development of an in vitro model of respiratory epithelial cells in idiopathic pulmonary fibrosis. J Pharmacol Toxicol Methods. 2017;86:19\u201327. https:\/\/doi.org\/10.1016\/j.vascn.2017.02.023.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"3504_CR151","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/imcb.12756","volume":"102","author":"D Li","year":"2024","unstructured":"Li D, Zhang X, Song Z, Zhao S, Huang Y, Qian W, et al. Advances in common in vitro cellular models of pulmonary fibrosis. Immunol Cell Biol. 2024;102:557\u201369.","journal-title":"Immunol Cell Biol"},{"key":"3504_CR152","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1183\/09059180.00003613","volume":"22","author":"C Vancheri","year":"2013","unstructured":"Vancheri C. Common pathways in idiopathic pulmonary fibrosis and cancer. Eur Respir Rev. 2013;22:265\u201372.","journal-title":"Eur Respir Rev"},{"key":"3504_CR153","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.7150\/thno.93519","volume":"14","author":"E V\u00e1squez-Pacheco","year":"2024","unstructured":"V\u00e1squez-Pacheco E, Marega M, Lingampally A, Fassy J, Truchi M, Goth K, et al. Highlighting fibroblast plasticity in lung fibrosis: the WI-38 cell line as a model for investigating the myofibroblast and lipofibroblast switch. Theranostics. 2024;14:3603\u201322.","journal-title":"Theranostics"},{"key":"3504_CR154","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1465-9921-7-88","volume":"7","author":"KL Watts","year":"2006","unstructured":"Watts KL, Cottrell E, Hoban PR, Spiteri MA. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis. Respir Res. 2006;7:88.","journal-title":"Respir Res"},{"key":"3504_CR155","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/cr.2012.175","volume":"23","author":"G Liang","year":"2013","unstructured":"Liang G, Zhang Y. Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Cell Res. 2013;23:49\u201369.","journal-title":"Cell Res"},{"key":"3504_CR156","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41580-018-0020-3","volume":"19","author":"M Ermolaeva","year":"2018","unstructured":"Ermolaeva M, Neri F, Ori A, Rudolph KL. Cellular and epigenetic drivers of stem cell ageing. Nat Rev Mol Cell Biol. 2018;19:594\u2013610.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3504_CR157","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s13770-022-00458-0","volume":"19","author":"H Kotasov\u00e1","year":"2022","unstructured":"Kotasov\u00e1 H, Capandov\u00e1 M, Pelkov\u00e1 V, Dumkov\u00e1 J, Koledov\u00e1 Z, Rem\u0161\u00edk J, et al. Expandable lung epithelium differentiated from human embryonic stem cells. Tissue Eng Regen Med. 2022;19:1033\u201350.","journal-title":"Tissue Eng Regen Med"},{"key":"3504_CR158","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1096\/fj.201902926R","volume":"34","author":"E Schruf","year":"2020","unstructured":"Schruf E, Schroeder V, Le HQ, Sch\u00f6nberger T, Raedel D, Stewart EL, et al. Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC-derived air-liquid interface model. FASEB J. 2020;34:7825\u201346.","journal-title":"FASEB J"},{"issue":"8","key":"3504_CR159","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202201853","volume":"6","author":"V Ptasinski","year":"2023","unstructured":"Ptasinski V, Monkley SJ, \u00d6st K, Tammia M, Alsafadi HN, Overed-Sayer C, et al. Modeling fibrotic alveolar transitional cells with pluripotent stem cell-derived alveolar organoids. Life Sci Alliance. 2023;6(8):e202201853. https:\/\/doi.org\/10.26508\/lsa.202201853.","journal-title":"Life Sci Alliance"},{"key":"3504_CR160","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00011-025-02041-4","volume":"74","author":"T Portakal","year":"2025","unstructured":"Portakal T, Havl\u00ed\u010dek V, Her\u016fdkov\u00e1 J, Pelkov\u00e1 V, Gruntov\u00e1 T, \u00c7akmakci RC, et al. Lipopolysaccharide induces retention of E-cadherin in the endoplasmic reticulum and promotes hybrid epithelial-to-mesenchymal transition of human embryonic stem cells-derived expandable lung epithelial cells. Inflamm Res. 2025;74:82.","journal-title":"Inflamm Res"},{"key":"3504_CR161","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1039\/D2BM01473D","volume":"11","author":"E Kawase","year":"2023","unstructured":"Kawase E, Nakatsuji N. Development of substrates for the culture of human pluripotent stem cells. Biomater Sci. 2023;11:2974\u201387.","journal-title":"Biomater Sci"},{"issue":"7","key":"3504_CR162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041643","volume":"7","author":"P Blanc","year":"2012","unstructured":"Blanc P, Coste K, Pouchin P, Aza\u00efs J-M, Blanchon L, Gallot D, et al. A role for mesenchyme dynamics in mouse lung branching morphogenesis. PLoS ONE. 2012;7(7):e41643. https:\/\/doi.org\/10.1371\/journal.pone.0041643.","journal-title":"PLoS ONE"},{"key":"3504_CR163","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1465-9921-11-162","volume":"11","author":"SR Franzd\u00f3ttir","year":"2010","unstructured":"Franzd\u00f3ttir SR, Axelsson IT, Arason AJ, Baldursson \u00d3, Gudjonsson T, Magnusson MK. Airway branching morphogenesis in three dimensional culture. Respir Res. 2010;11:162.","journal-title":"Respir Res"},{"key":"3504_CR164","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nature01712","volume":"423","author":"T Sakai","year":"2003","unstructured":"Sakai T, Larsen M, Yamada KM. Fibronectin requirement in branching morphogenesis. Nature. 2003;423:876\u201381.","journal-title":"Nature"},{"key":"3504_CR165","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1039\/C3BM60319A","volume":"2","author":"ME Smithmyer","year":"2014","unstructured":"Smithmyer ME, Sawicki LA, Kloxin AM. Hydrogel scaffolds as in vitro models to study fibroblast activation in wound healing and disease. Biomater Sci. 2014;2:634\u201350.","journal-title":"Biomater Sci"},{"key":"3504_CR166","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1021\/acsnano.9b06860","volume":"14","author":"H Barosova","year":"2020","unstructured":"Barosova H, Maione AG, Septiadi D, Sharma M, Haeni L, Balog S, et al. Use of EpiAlveolar Lung Model to predict fibrotic potential of multiwalled carbon nanotubes. ACS Nano. 2020;14:3941\u201356.","journal-title":"ACS Nano"},{"key":"3504_CR167","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41598-023-50618-y","volume":"14","author":"SL Barron","year":"2024","unstructured":"Barron SL, Wyatt O, O\u2019Connor A, Mansfield D, Suzanne Cohen E, Witkos TM, et al. Modelling bronchial epithelial-fibroblast cross-talk in idiopathic pulmonary fibrosis (IPF) using a human-derived in vitro air liquid interface (ALI) culture. Sci Rep. 2024;14:240.","journal-title":"Sci Rep"},{"key":"3504_CR168","doi-asserted-by":"publisher","first-page":"8054","DOI":"10.1038\/srep08054","volume":"5","author":"M Hagiwara","year":"2015","unstructured":"Hagiwara M, Peng F, Ho C-M. In vitro reconstruction of branched tubular structures from lung epithelial cells in high cell concentration gradient environment. Sci Rep. 2015;5:8054.","journal-title":"Sci Rep"},{"issue":"171","key":"3504_CR169","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0127-2023","volume":"33","author":"E Kolanko","year":"2024","unstructured":"Kolanko E, Cargnoni A, Papait A, Silini AR, Czekaj P, Parolini O. The evolution of in vitro models of lung fibrosis: promising prospects for drug discovery. Eur Respir Rev. 2024;33(171):230127. https:\/\/doi.org\/10.1183\/16000617.0127-2023.","journal-title":"Eur Respir Rev"},{"key":"3504_CR170","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ddtec.2017.03.002","volume":"23","author":"S Sant","year":"2017","unstructured":"Sant S, Johnston PA. The production of 3D tumor spheroids for cancer drug discovery. Drug Discov Today Technol. 2017;23:27\u201336. https:\/\/doi.org\/10.1016\/j.ddtec.2017.03.002.","journal-title":"Drug Discov Today Technol"},{"key":"3504_CR171","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.5966\/sctm.2015-0062","volume":"4","author":"E Henry","year":"2015","unstructured":"Henry E, Cores J, Hensley MT, Anthony S, Vandergriff A, de Andra JB, et al. Adult lung spheroid cells contain progenitor cells and mediate regeneration in rodents with bleomycin-induced pulmonary fibrosis. Stem Cells Transl Med. 2015;4:1265\u201374.","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"3504_CR172","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91377","volume":"2","author":"R Surolia","year":"2017","unstructured":"Surolia R, Li FJ, Wang Z, Li H, Liu G, Zhou Y, et al. 3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs. JCI Insight. 2017;2(2):e91377. https:\/\/doi.org\/10.1172\/jci.insight.91377.","journal-title":"JCI Insight"},{"key":"3504_CR173","doi-asserted-by":"publisher","first-page":"1247125","DOI":"10.1126\/science.1247125","volume":"345","author":"MA Lancaster","year":"2014","unstructured":"Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014;345:1247125.","journal-title":"Science"},{"issue":"2","key":"3504_CR174","doi-asserted-by":"publisher","first-page":"622","DOI":"10.5966\/sctm.2016-0192","volume":"6","author":"DC Wilkinson","year":"2017","unstructured":"Wilkinson DC, Alva-Ornelas JA, Sucre JM, Vijayaraj P, Durra A, Richardson W, et al. Development of a three-dimensional bioengineering technology to generate lung tissue for personalized disease modeling. Stem Cells Transl Med. 2017;6(2):622\u201333. https:\/\/doi.org\/10.5966\/sctm.2016-0192.","journal-title":"Stem Cells Transl Med"},{"key":"3504_CR175","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1016\/j.celrep.2019.05.077","volume":"27","author":"A Strikoudis","year":"2019","unstructured":"Strikoudis A, Cie\u015blak A, Loffredo L, Chen YW, Patel N, Saqi A, et al. Modeling of fibrotic lung disease using 3D organoids derived from human pluripotent stem cells. Cell Rep. 2019;27:3709-3723.e3705.","journal-title":"Cell Rep"},{"key":"3504_CR176","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12931-024-02666-9","volume":"25","author":"S Blumer","year":"2024","unstructured":"Blumer S, Khan P, Artysh N, Plappert L, Savic S, Knudsen L, et al. The use of cultured human alveolar basal cells to mimic honeycomb formation in idiopathic pulmonary fibrosis. Respir Res. 2024;25:26.","journal-title":"Respir Res"},{"issue":"21","key":"3504_CR177","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019103476","volume":"39","author":"AI Vazquez\u2010Armendariz","year":"2020","unstructured":"Vazquez\u2010Armendariz AI, Heiner M, El Agha E, Salwig I, Hoek A, Hessler MC, et al. Multilineage murine stem cells generate complex organoids to model distal lung development and disease. EMBO J. 2020;39(21):e103476. https:\/\/doi.org\/10.15252\/embj.2019103476.","journal-title":"EMBO J"},{"key":"3504_CR178","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nmeth.4448","volume":"14","author":"Y Yamamoto","year":"2017","unstructured":"Yamamoto Y, Gotoh S, Korogi Y, Seki M, Konishi S, Ikeo S, et al. Long-term expansion of alveolar stem cells derived from human iPS cells in organoids. Nat Methods. 2017;14:1097\u2013106.","journal-title":"Nat Methods"},{"key":"3504_CR179","doi-asserted-by":"publisher","DOI":"10.34133\/bmr.0171","volume":"29","author":"Q Yang","year":"2025","unstructured":"Yang Q, Li M, Xiao Z, Feng Y, Lei L, Li S. A new perspective on precision medicine. The power of digital organoids. Biomater Res. 2025;29:0171.","journal-title":"Biomater Res"},{"issue":"7","key":"3504_CR180","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.240413","volume":"11","author":"H Coggan","year":"2024","unstructured":"Coggan H, Weeden CE, Pearce P, Dalwadi MP, Magness A, Swanton C, et al. An agent-based modelling framework to study growth mechanisms in EGFR-L858R mutant cell alveolar type II cells. R Soc Open Sci. 2024;11(7):240413. https:\/\/doi.org\/10.1098\/rsos.240413.","journal-title":"R Soc Open Sci"},{"key":"3504_CR181","doi-asserted-by":"crossref","unstructured":"Sedlakova V, Ruel M, Suuronen EJ. Therapeutic use of bioengineered materials for myocardial infarction. In: Edited by Alarcon EI, Ahumada M, editors. Nanoengineering Materials for Biomedical Uses. Cham: Springer International Publishing; 2019. p. 161\u2013193.","DOI":"10.1007\/978-3-030-31261-9_9"},{"issue":"24","key":"3504_CR182","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1016\/S0142-9612(03)00340-5","volume":"24","author":"JL Drury","year":"2003","unstructured":"Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 2003;24(24):4337\u201351. https:\/\/doi.org\/10.1016\/S0142-9612(03)00340-5.","journal-title":"Biomaterials"},{"key":"3504_CR183","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/COPD.S1119","volume":"3","author":"SE Dunsmore","year":"2008","unstructured":"Dunsmore SE. Treatment of COPD: a matrix perspective. Int J Chron Obstruct Pulmon Dis. 2008;3:113\u201322.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3504_CR184","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1165\/rcmb.2020-0227OC","volume":"63","author":"A Berhan","year":"2020","unstructured":"Berhan A, Harris T, Jaffar J, Jativa F, Langenbach S, L\u00f6nnstedt I, et al. Cellular microenvironment stiffness regulates eicosanoid production and signaling pathways. Am J Respir Cell Mol Biol. 2020;63:819\u201330.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"3504_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2022.151253","volume":"101","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Wang P, Fang X, Lin F, Fang J, Xiong C. Collagen gel contraction assays: from modelling wound healing to quantifying cellular interactions with three-dimensional extracellular matrices. Eur J Cell Biol. 2022;101(3):151253. https:\/\/doi.org\/10.1016\/j.ejcb.2022.151253.","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"3504_CR186","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/01.RES.88.1.77","volume":"88","author":"JA Travis","year":"2001","unstructured":"Travis JA, Hughes MG, Wong JM, Wagner WD, Geary RL. Hyaluronan enhances contraction of collagen by smooth muscle cells and adventitial fibroblasts: role of CD44 and implications for constrictive remodeling. Circ Res. 2001;88(1):77\u201383. https:\/\/doi.org\/10.1161\/01.RES.88.1.77.","journal-title":"Circ Res"},{"key":"3504_CR187","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev.cellbio.042308.113318","volume":"26","author":"F Grinnell","year":"2010","unstructured":"Grinnell F, Petroll WM. Cell motility and mechanics in three-dimensional collagen matrices. Annu Rev Cell Dev Biol. 2010;26:335\u201361.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"9","key":"3504_CR188","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13281","volume":"5","author":"S Asano","year":"2017","unstructured":"Asano S, Ito S, Takahashi K, Furuya K, Kondo M, Sokabe M, et al. Matrix stiffness regulates migration of human lung fibroblasts. Physiol Rep. 2017;5(9):e13281. https:\/\/doi.org\/10.14814\/phy2.13281.","journal-title":"Physiol Rep"},{"key":"3504_CR189","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb5069","volume":"6","author":"DL Matera","year":"2020","unstructured":"Matera DL, DiLillo KM, Smith MR, Davidson CD, Parikh R, Said M, et al. Microengineered 3D pulmonary interstitial mimetics highlight a critical role for matrix degradation in myofibroblast differentiation. Sci Adv. 2020;6:eabb5069.","journal-title":"Sci Adv"},{"key":"3504_CR190","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1016\/j.celrep.2019.11.019","volume":"29","author":"P Vijayaraj","year":"2019","unstructured":"Vijayaraj P, Minasyan A, Durra A, Karumbayaram S, Mehrabi M, Aros CJ, et al. Modeling progressive fibrosis with pluripotent stem cells identifies an anti-fibrotic small molecule. Cell Rep. 2019;29:3488-3505.e3489.","journal-title":"Cell Rep"},{"issue":"1","key":"3504_CR191","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.37824","volume":"113","author":"M Capandova","year":"2025","unstructured":"Capandova M, Sedlakova V, Vorac Z, Kotasova H, Dumkova J, Moran L, et al. Using polycaprolactone nanofibers for the proof-of-concept construction of the alveolar-capillary interface. J Biomed Mater Res A. 2025;113(1):e37824. https:\/\/doi.org\/10.1002\/jbm.a.37824.","journal-title":"J Biomed Mater Res A"},{"issue":"1","key":"3504_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ten.tec.2017.0283","volume":"24","author":"Z Garl\u00edkov\u00e1","year":"2018","unstructured":"Garl\u00edkov\u00e1 Z, Silva AC, Rabata A, Pot\u011b\u0161il D, Ihnatov\u00e1 I, Dumkov\u00e1 J, et al. Generation of a close-to-native in vitro system to study lung cells-extracellular matrix crosstalk. Tissue Eng Part C Methods. 2018;24(1):1\u201313. https:\/\/doi.org\/10.1089\/ten.tec.2017.0283.","journal-title":"Tissue Eng Part C Methods"},{"issue":"3","key":"3504_CR193","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.healun.2013.10.030","volume":"33","author":"SE Gilpin","year":"2014","unstructured":"Gilpin SE, Guyette JP, Gonzalez G, Ren X, Asara JM, Mathisen DJ, et al. Perfusion decellularization of human and porcine lungs: bringing the matrix to clinical scale. J Heart Lung Transplant. 2014;33(3):298\u2013308. https:\/\/doi.org\/10.1016\/j.healun.2013.10.030.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"3504_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35011-z","volume":"13","author":"O Rosmark","year":"2023","unstructured":"Rosmark O, Kadefors M, Dellgren G, Karlsson C, Ericsson A, Lindstedt S, et al. Alveolar epithelial cells are competent producers of interstitial extracellular matrix with disease relevant plasticity in a human in vitro 3D model. Sci Rep. 2023;13(1):8801. https:\/\/doi.org\/10.1038\/s41598-023-35011-z.","journal-title":"Sci Rep"},{"issue":"8","key":"3504_CR195","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/jbm.a.35726","volume":"104","author":"RA Pouliot","year":"2016","unstructured":"Pouliot RA, Link PA, Mikhaiel NS, Schneck MB, Valentine MS, Kamga Gninzeko FJ, et al. Development and characterization of a naturally derived lung extracellular matrix hydrogel. J Biomed Mater Res A. 2016;104(8):1922\u201335. https:\/\/doi.org\/10.1002\/jbm.a.35726.","journal-title":"J Biomed Mater Res A"},{"issue":"6","key":"3504_CR196","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061538","volume":"10","author":"M Dabaghi","year":"2021","unstructured":"Dabaghi M, Saraei N, Carpio MB, Nanduri V, Ungureanu J, Babi M, et al. A robust protocol for decellularized human lung bioink generation amenable to 2D and 3D lung cell culture. Cells. 2021;10(6):1538. https:\/\/doi.org\/10.3390\/cells10061538.","journal-title":"Cells"},{"issue":"4","key":"3504_CR197","doi-asserted-by":"publisher","first-page":"L698","DOI":"10.1152\/ajplung.00451.2019","volume":"318","author":"RHJ de Hilster","year":"2020","unstructured":"de Hilster RHJ, Sharma PK, Jonker MR, White ES, Gercama EA, Roobeek M, et al. Human lung extracellular matrix hydrogels resemble the stiffness and viscoelasticity of native lung tissue. Am J Physiol Lung Cell Mol Physiol. 2020;318(4):L698-l704. https:\/\/doi.org\/10.1152\/ajplung.00451.2019.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3504_CR198","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E23-11-0428","volume":"35","author":"JG Fernandez Davila","year":"2024","unstructured":"Fernandez Davila JG, Singh AK, Moore DW, Kim J, Khan JA, Lemma M, et al. Pulmonary matrix-derived hydrogels from patients with idiopathic pulmonary fibrosis induce a proinflammatory state in lung fibroblasts in vitro. Mol Biol Cell. 2024;35:ar114.","journal-title":"Mol Biol Cell"},{"issue":"31","key":"3504_CR199","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1039\/D0TB00613K","volume":"8","author":"CL Petrou","year":"2020","unstructured":"Petrou CL, D\u2019Ovidio TJ, B\u00f6l\u00fckbas DA, Tas S, Brown RD, Allawzi A, et al. Clickable decellularized extracellular matrix as a new tool for building hybrid-hydrogels to model chronic fibrotic diseases in vitro. J Mater Chem B. 2020;8(31):6814\u201326. https:\/\/doi.org\/10.1039\/D0TB00613K.","journal-title":"J Mater Chem B"},{"issue":"5","key":"3504_CR200","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12195-022-00726-y","volume":"15","author":"KS Saleh","year":"2022","unstructured":"Saleh KS, Hewawasam R, \u0160erbed\u017eija P, Blomberg R, Noreldeen SE, Edelman B, et al. Engineering Hybrid-Hydrogels Comprised of Healthy or Diseased Decellularized Extracellular Matrix to Study Pulmonary Fibrosis. Cell Mol Bioeng. 2022;15(5):505\u201319. https:\/\/doi.org\/10.1007\/s12195-022-00726-y.","journal-title":"Cell Mol Bioeng"},{"key":"3504_CR201","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.biomaterials.2016.06.025","volume":"102","author":"JL Balestrini","year":"2016","unstructured":"Balestrini JL, Gard AL, Gerhold KA, Wilcox EC, Liu A, Schwan J, et al. Comparative biology of decellularized lung matrix: implications of species mismatch in regenerative medicine. Biomaterials. 2016;102:220\u201330. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.06.025.","journal-title":"Biomaterials"},{"key":"3504_CR202","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.actbio.2023.06.043","volume":"168","author":"E Hoffman","year":"2023","unstructured":"Hoffman E, Song Y, Zhang F, Asarian L, Downs I, Young B, et al. Regional and disease-specific glycosaminoglycan composition and function in decellularized human lung extracellular matrix. Acta Biomater. 2023;168:388\u201399.","journal-title":"Acta Biomater"},{"issue":"1","key":"3504_CR203","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04336-z","volume":"9","author":"M Asmani","year":"2018","unstructured":"Asmani M, Velumani S, Li Y, Wawrzyniak N, Hsia I, Chen Z, et al. Fibrotic microtissue array to predict anti-fibrosis drug efficacy. Nat Commun. 2018;9(1):2066. https:\/\/doi.org\/10.1038\/s41467-018-04336-z.","journal-title":"Nat Commun"},{"issue":"9","key":"3504_CR204","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1164\/rccm.201204-0754OC","volume":"186","author":"AJ Booth","year":"2012","unstructured":"Booth AJ, Hadley R, Cornett AM, Dreffs AA, Matthes SA, Tsui JL, et al. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med. 2012;186(9):866\u201376. https:\/\/doi.org\/10.1164\/rccm.201204-0754OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3504_CR205","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201700506","volume":"7","author":"S Ahadian","year":"2018","unstructured":"Ahadian S, Civitarese R, Bannerman D, Mohammadi MH, Lu R, Wang E, et al. Organ-On-A-Chip Platforms: a convergence of advanced materials, cells, and microscale technologies. Adv Healthc Mater. 2018;7(2):1700506. https:\/\/doi.org\/10.1002\/adhm.201700506.","journal-title":"Adv Healthc Mater"},{"issue":"5986","key":"3504_CR206","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.1188302","volume":"328","author":"D Huh","year":"2010","unstructured":"Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science. 2010;328(5986):1662\u20138. https:\/\/doi.org\/10.1126\/science.1188302.","journal-title":"Science"},{"key":"3504_CR207","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004249","volume":"4","author":"D Huh","year":"2012","unstructured":"Huh D, Leslie DC, Matthews BD, Fraser JP, Jurek S, Hamilton GA, et al. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med. 2012;4:159ra147.","journal-title":"Sci Transl Med"},{"issue":"4","key":"3504_CR208","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41551-019-0498-9","volume":"4","author":"A Herland","year":"2020","unstructured":"Herland A, Maoz BM, Das D, Somayaji MR, Prantil-Baun R, Novak R, et al. Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips. Nat Biomed Eng. 2020;4(4):421\u201336. https:\/\/doi.org\/10.1038\/s41551-019-0498-9.","journal-title":"Nat Biomed Eng"},{"issue":"24","key":"3504_CR209","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1039\/C8LC01029C","volume":"18","author":"D Bovard","year":"2018","unstructured":"Bovard D, Sandoz A, Luettich K, Frentzel S, Iskandar A, Marescotti D, et al. A lung\/liver-on-a-chip platform for acute and chronic toxicity studies. Lab Chip. 2018;18(24):3814\u201329. https:\/\/doi.org\/10.1039\/C8LC01029C.","journal-title":"Lab Chip"},{"key":"3504_CR210","doi-asserted-by":"publisher","DOI":"10.1002\/cnm.2955","volume":"34","author":"RR Kannan","year":"2018","unstructured":"Kannan RR, Singh N, Przekwas A. A compartment-quasi-3D multiscale approach for drug absorption, transport, and retention in the human lungs. Int J Numer Meth Biomed Eng. 2018;34:e2955.","journal-title":"Int J Numer Meth Biomed Eng"},{"issue":"7","key":"3504_CR211","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1002\/bit.28426","volume":"120","author":"C Shen","year":"2023","unstructured":"Shen C, Yang H, She W, Meng Q. A microfluidic lung-on-a-chip based on biomimetic hydrogel membrane. Biotechnol Bioeng. 2023;120(7):2027\u201338. https:\/\/doi.org\/10.1002\/bit.28426.","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"3504_CR212","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/adb338","volume":"17","author":"J Xia","year":"2025","unstructured":"Xia J, Dong R, Fang Y, Guo J, Xiong Z, Zhang T, et al. A micro-lung chip with macrophages for targeted anti-fibrotic therapy. Biofabrication. 2025;17(2):025020.","journal-title":"Biofabrication"},{"key":"3504_CR213","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2019.00003","volume":"7","author":"M Felder","year":"2019","unstructured":"Felder M, Trueeb B, Stucki AO, Borcard S, Stucki JD, Schnyder B, et al. Impaired wound healing of alveolar lung epithelial cells in a breathing lung-on-a-chip. Front Bioeng Biotechnol. 2019;7:3. https:\/\/doi.org\/10.3389\/fbioe.2019.00003.","journal-title":"Front Bioeng Biotechnol"},{"issue":"41","key":"3504_CR214","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202205083","volume":"34","author":"A Doryab","year":"2022","unstructured":"Doryab A, Taskin MB, Stahlhut P, Groll J, Schmid O. Real-time measurement of cell mechanics as a clinically relevant readout of an in vitro lung fibrosis model established on a bioinspired basement membrane. Adv Mater. 2022;34(41):2205083. https:\/\/doi.org\/10.1002\/adma.202205083.","journal-title":"Adv Mater"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03504-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03504-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03504-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:02:32Z","timestamp":1765436552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03504-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":214,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3504"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03504-4","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1232"}}